CN105076994A - 治疗肝硬化的山药饼及其制备方法 - Google Patents
治疗肝硬化的山药饼及其制备方法 Download PDFInfo
- Publication number
- CN105076994A CN105076994A CN201510554570.XA CN201510554570A CN105076994A CN 105076994 A CN105076994 A CN 105076994A CN 201510554570 A CN201510554570 A CN 201510554570A CN 105076994 A CN105076994 A CN 105076994A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese yam
- cake
- cirrhosis
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000019425 cirrhosis of liver Diseases 0.000 title claims abstract description 61
- 230000007882 cirrhosis Effects 0.000 title claims abstract description 59
- 206010016654 Fibrosis Diseases 0.000 title claims abstract description 58
- 238000002360 preparation method Methods 0.000 title claims description 24
- 239000002994 raw material Substances 0.000 claims abstract description 38
- 235000011430 Malus pumila Nutrition 0.000 claims abstract description 33
- 235000015103 Malus silvestris Nutrition 0.000 claims abstract description 33
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 33
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 33
- 244000000626 Daucus carota Species 0.000 claims abstract description 32
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 32
- 235000000832 Ayote Nutrition 0.000 claims abstract description 29
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 29
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 29
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 29
- 240000004244 Cucurbita moschata Species 0.000 claims abstract description 27
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 25
- 244000205574 Acorus calamus Species 0.000 claims abstract description 21
- 235000011996 Calamus deerratus Nutrition 0.000 claims abstract description 21
- 241000511967 Tylophora Species 0.000 claims abstract description 21
- 241000723221 Crepis Species 0.000 claims abstract description 20
- 244000068988 Glycine max Species 0.000 claims abstract description 19
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 19
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 79
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 79
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 79
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 79
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- 241000220225 Malus Species 0.000 claims description 29
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 29
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 29
- 235000013312 flour Nutrition 0.000 claims description 29
- 241000110637 Cuscuta chinensis Species 0.000 claims description 21
- 238000009835 boiling Methods 0.000 claims description 11
- 238000000855 fermentation Methods 0.000 claims description 11
- 230000004151 fermentation Effects 0.000 claims description 11
- 235000012907 honey Nutrition 0.000 claims description 11
- 239000003755 preservative agent Substances 0.000 claims description 11
- 230000002335 preservative effect Effects 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 8
- 235000015895 biscuits Nutrition 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 235000011194 food seasoning agent Nutrition 0.000 claims description 7
- 210000002966 serum Anatomy 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 238000009423 ventilation Methods 0.000 claims description 7
- 210000004185 liver Anatomy 0.000 abstract description 18
- 210000002784 stomach Anatomy 0.000 abstract description 17
- 210000000582 semen Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 26
- 230000000694 effects Effects 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 150000003722 vitamin derivatives Chemical class 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000005229 liver cell Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 206010025482 malaise Diseases 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 235000007686 potassium Nutrition 0.000 description 5
- 206010000060 Abdominal distension Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 208000007232 portal hypertension Diseases 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000050051 Chelone glabra Species 0.000 description 3
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 3
- 206010019799 Hepatitis viral Diseases 0.000 description 3
- 239000005717 Laminarin Substances 0.000 description 3
- 229920001543 Laminarin Polymers 0.000 description 3
- 244000081841 Malus domestica Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 240000007164 Salvia officinalis Species 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000000783 alginic acid Substances 0.000 description 3
- 229960001126 alginic acid Drugs 0.000 description 3
- 150000004781 alginic acids Chemical class 0.000 description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 3
- 229960002747 betacarotene Drugs 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 208000007386 hepatic encephalopathy Diseases 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 238000005461 lubrication Methods 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 3
- 235000005412 red sage Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 201000004409 schistosomiasis Diseases 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- YFEPHJVWLFGWKH-CQSZACIVSA-N (13ar)-2,3,5,6-tetramethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f]indolizine Chemical compound C12=CC(OC)=C(OC)C=C2C2=C(OC)C(OC)=CC=C2C2=C1C[C@H]1CCCN1C2 YFEPHJVWLFGWKH-CQSZACIVSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 241000233788 Arecaceae Species 0.000 description 2
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 206010010075 Coma hepatic Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 206010063075 Cryptogenic cirrhosis Diseases 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000112528 Ligusticum striatum Species 0.000 description 2
- 206010030124 Oedema peripheral Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000002151 Pleural effusion Diseases 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000012654 Primary biliary cholangitis Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 206010041519 Spider naevus Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241001261505 Undaria Species 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000013475 authorization Methods 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000002603 extrahepatic bile duct Anatomy 0.000 description 2
- 208000003816 familial cirrhosis Diseases 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 201000001059 hepatic coma Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 201000004108 hypersplenism Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 208000001024 intrahepatic cholestasis Diseases 0.000 description 2
- 230000007872 intrahepatic cholestasis Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000014786 phosphorus Nutrition 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- NKQJVOJUSQJZPX-QMMMGPOBSA-N (2S)-3-(3,4-dihydroxyphenyl)-2-(ethylamino)propanoic acid Chemical compound CCN[C@@H](Cc1ccc(O)c(O)c1)C(O)=O NKQJVOJUSQJZPX-QMMMGPOBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- CVOFKRWYWCSDMA-UHFFFAOYSA-N 2-chloro-n-(2,6-diethylphenyl)-n-(methoxymethyl)acetamide;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)aniline Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl.CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O CVOFKRWYWCSDMA-UHFFFAOYSA-N 0.000 description 1
- YTRMTPPVNRALON-UHFFFAOYSA-N 2-phenyl-4-quinolinecarboxylic acid Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=CC=C1 YTRMTPPVNRALON-UHFFFAOYSA-N 0.000 description 1
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical group O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000209495 Acorus Species 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- 241000199899 Alariaceae Species 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 240000000966 Allium tricoccum Species 0.000 description 1
- 235000006905 Allium tricoccum Nutrition 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 241000415078 Anemone hepatica Species 0.000 description 1
- 101710081722 Antitrypsin Proteins 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010054936 Cardiac cirrhosis Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000258920 Chilopoda Species 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000207782 Convolvulaceae Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- 241000404450 Crepis acuminata Species 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- 240000007175 Datura inoxia Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 241000237890 Haliotis Species 0.000 description 1
- 241000143510 Haliotis discus hannai Species 0.000 description 1
- 241001489138 Haliotis diversicolor Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 208000018565 Hemochromatosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- 241001466452 Laminariaceae Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000003433 Miscanthus floridulus Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000581835 Monodora junodii Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010034023 Parotid gland enlargement Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 206010034487 Pericarditis constrictive Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241001442514 Schistosomatidae Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 240000003705 Senecio vulgaris Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 235000008950 Sommerlauch Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- SSEUDFYBEOIWGF-AWEZNQCLSA-N Tylophorine Chemical compound C1=C(OC)C(OC)=CC2=C(C=C(C(OC)=C3)OC)C3=C(C[C@H]3N(CCC3)C3)C3=C21 SSEUDFYBEOIWGF-AWEZNQCLSA-N 0.000 description 1
- SSEUDFYBEOIWGF-CQSZACIVSA-N Tylophorine Natural products C1=C(OC)C(OC)=CC2=C(C=C(C(OC)=C3)OC)C3=C(C[C@@H]3N(CCC3)C3)C3=C21 SSEUDFYBEOIWGF-CQSZACIVSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001475 anti-trypsic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 125000001409 beta-carotene group Chemical group 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 229960002468 cinchophen Drugs 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 208000000839 constrictive pericarditis Diseases 0.000 description 1
- 238000004320 controlled atmosphere Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940111205 diastase Drugs 0.000 description 1
- 230000002478 diastatic effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- -1 glutinous albumen Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 201000000079 gynecomastia Diseases 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 208000001118 melena Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 229960003684 oxedrine Drugs 0.000 description 1
- PHPUXYRXPHEJDF-UHFFFAOYSA-N oxyphenisatine acetate Chemical compound C1=CC(OC(=O)C)=CC=C1C1(C=2C=CC(OC(C)=O)=CC=2)C2=CC=CC=C2NC1=O PHPUXYRXPHEJDF-UHFFFAOYSA-N 0.000 description 1
- 229950000967 oxyphenisatine acetate Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002910 solid waste Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- OBSZRRSYVTXPNB-UHFFFAOYSA-N tetraphosphorus Chemical compound P12P3P1P32 OBSZRRSYVTXPNB-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗肝硬化的山药饼,取下述重量配比的主要原料制备而成:山药30-80份,石决明2-6份,奶浆参6-10份,青皮5-10份,七层楼2-6份,昆布3-7份,菟丝子3-8份,菖蒲4-8份,马铃薯20-30份,苹果10-20份,胡萝卜10-30份,南瓜15-25份,大豆20-30份。本发明具有疏肝理气、养肝护胃和治疗肝硬化的功效,本发明原料药源易得,成本低廉,所选原料多为药性平和之物,长期使用也不会给使用者增加经济和身体上的负担。
Description
技术领域
本发明涉及中医中药领域,特别是涉及一种治疗肝硬化的山药饼及其制备方法。
背景技术
肝硬化是临床常见的慢性进行性肝病,由一种或多种病因长期或反复作用形成的弥漫性肝损害。在我国大多数为肝炎后肝硬化,少部分为酒精性肝硬化和血吸虫性肝硬化。病理组织学上有广泛的肝细胞坏死、残存肝细胞结节性再生、结缔组织增生与纤维隔形成,导致肝小叶结构破坏和假小叶形成,肝脏逐渐变形、变硬而发展为肝硬化。早期由于肝脏代偿功能较强可无明显症状,后期则以肝功能损害和门脉高压为主要表现,并有多系统受累,晚期常出现上消化道出血、肝性脑病、继发感染、脾功能亢进、腹水、癌变等并发症。
病因:引起肝硬化的病因很多,可分为病毒性肝炎肝硬化、酒精性肝硬化、代谢性肝硬化、胆汁淤积性肝硬化、肝静脉回流受阻性肝硬化、自身免疫性肝硬化、毒物和药物性肝硬化、营养不良性肝硬化、隐源性肝硬化等。1.病毒性肝炎:目前在中国,病毒性肝炎尤其是慢性乙型、丙型肝炎,是引起门静脉性肝硬化的主要因素。2.酒精中毒:长期大量酗酒,是引起肝硬化的因素之一。3.营养障碍:多数学者承认营养不良可降低肝细胞对有毒和传染因素的抵抗力,而成为肝硬化的间接病因。4.工业毒物或药物:长期或反复地接触含砷杀虫剂、四氯化碳、黄磷、氯仿等,或长期使用某些药物如双醋酚汀、异烟肼、辛可芬、四环素、氨甲蝶呤、甲基多巴,可产生中毒性或药物性肝炎,进而导致肝硬化。黄曲霉素也可使肝细胞发生中毒损害,引起肝硬化。5.循环障碍:慢性充血性心力衰竭、慢性缩窄性心包炎可使肝内长期淤血缺氧,引起肝细胞坏死和纤维化,称淤血性肝硬化,也称为心源性肝硬化。6.代谢障碍:如血色病和肝豆状核变性(亦称Wilson病)等。7.胆汁淤积:肝外胆管阻塞或肝内胆汁淤积时高浓度的胆红素对肝细胞有损害作用,久之可发生肝硬化,肝内胆汁淤积所致者称原发胆汁性肝硬化,由肝外胆管阻塞所致者称继发性胆汁性肝硬化。8.血吸虫病:血吸虫病时由于虫卵在汇管区刺激结缔组织增生成为血吸虫病性肝纤维化,可引起显著的门静脉高压,亦称为血吸虫病性肝硬化。9.原因不明:部分肝硬化原因不明,称为隐源性肝硬化。市场上常见的治疗肝硬化的大多为激素类药物,容易对新儿童以及肾炎严重的患者会给胃部造成刺激,加重病情。
临床表现:1.代偿期(一般属Child-PughA级)可有肝炎临床表现,亦可隐匿起病。可有轻度乏力、腹胀、肝脾轻度肿大、轻度黄疸,肝掌、蜘蛛痣。2.失代偿期(一般属Child-PughB、C级)有肝功损害及门脉高压症候群。(1)全身症状 乏力、消瘦、面色晦暗,尿少、下肢水肿。(2)消化道症状 食欲减退、腹胀、胃肠功能紊乱甚至吸收不良综合征,肝源性糖尿病,可出现多尿、多食等症状。(3)出血倾向及贫血 齿龈出血、鼻衄、紫癜、贫血。(4)内分泌障碍 蜘蛛痣、肝掌、皮肤色素沉着、女性月经失调、男性乳房发育、腮腺肿大。(5)低蛋血症 双下肢水肿、尿少、腹腔积液、肝源性胸腔积液。
(6)门脉高压 腹腔积液、胸腔积液、脾大、脾功能亢进、门脉侧支循环建立、食管-胃底静脉曲张,腹壁静脉曲张。
在现有治疗肝硬化的专利中,授权公告号CN103417629B(申请号201310381571.X)公开了一种治疗乙肝肝硬化的中药,其特征在于,该中药是由以下重量份数计的:石决明7-10份、丹参4-7份、黄芩3-6份和川芎4-5份制成,其中,将石决明、丹参、黄芩、川芎粉碎成粗粉,加入石决明、丹参、黄芩、川芎8-10倍重量的体积浓度为75-98%的乙醇,室温下,震摇8-10天,过滤,得滤液,在45℃时,旋转去除乙醇,常规干燥成固态,粉碎成中药粉。授权公告号CN102488804B(申请号201110423612.8)的专利公开了一种治疗肝硬化的中药,其特征在于:它是由以下重量份的药材组成:牛黄0.15-0.35份、桃仁5-10份、西洋参3-6份、桂枝3-10份、黄芪9-30份、姜半夏3-9份、乳香3-5份、昆布6-12份。
由此可见,中药在治疗肝硬化方面占有非常重要的地位,但是大多数为纯中药制剂,不适宜长期服用。
发明内容
针对现有技术的不足,本发明的目的之一在于提供一种的治疗肝硬化的山药饼,具有疏肝理气、养肝护胃和治疗肝硬化的功效,本发明原料药源易得,成本低廉,所选原料多为药性平和之物,长期使用也不会给使用者增加经济和身体上的负担。
本发明的另一目的就是提供上述治疗肝硬化的山药饼的制备方法。
本发明的技术方案是:
治疗肝硬化的山药饼,取下述重量配比的主要原料制备而成:山药30-80份,石决明2-6份,奶浆参6-10份,青皮5-10份,七层楼2-6份,昆布3-7份,菟丝子3-8份,菖蒲4-8份,马铃薯20-30份,苹果10-20份,胡萝卜10-30份,南瓜15-25份,大豆20-30份。
治疗肝硬化的山药饼,优选的方案为,取下述重量配比的主要原料制备而成:山药40-70份,石决明3-5份,奶浆参7-9份,青皮6-9份,七层楼3-5份,昆布4-6份,菟丝子4-7份,菖蒲5-7份,马铃薯23-28份,苹果13-18份,胡萝卜15-25份,南瓜18-23份,大豆23-28份。
治疗肝硬化的山药饼,更为优选的方案为,取下述重量配比的主要原料制备而成:山药55份,石决明4份,奶浆参8份,青皮7.5份,七层楼4份,昆布5份,菟丝子5.5份,菖蒲6份,马铃薯25份,苹果15份,胡萝卜20份,南瓜20份,大豆25份。
上述治疗肝硬化的山药饼的制备方法,步骤如下:
1)选材:选直径为1-3厘米,长15-20厘米的山药,选用色泽鲜艳皮薄的马铃薯,苹果选择水分少的,胡萝卜要选择白色水分多的,选用金黄色的圆的南瓜;
2)预处理:将山药、马铃薯、苹果、胡萝卜和南瓜分别清洗干净,去皮,再用清水冲洗2遍,切成硬币大小的方块,隔水蒸煮20-40分钟;
3)打浆:将预处理好的原料放入打浆机内并且加入原料重量0.2-0.6倍的蜂蜜,然后进行打浆,得到混合浆液;
4)制备辅料:将石决明、奶浆参、青皮、七层楼、昆布、菟丝子和菖蒲用清水清洗3遍,置于铁丝网上,于阴凉通风处,沥干水分,紫外杀菌后加入到粉碎机,粉碎成细末,过80-120目筛;
5)制备佐料,将大豆碾磨成豆面,过120-160目筛,将过筛后的豆面置于容器内,放入豆面2-3倍的面粉,加水,用筷子搅拌,待用手捏成团时用保鲜膜包裹发酵10-20分钟待用;
6)制备成品:将步骤3)与步骤4)所得物混匀,然后倒入步骤5)发酵好的面团里,用力揉搓成团,放入挤压机制成直径3-7cm,厚0.3-0.7cm的饼,油炸,油温控制在140-200℃,时间为2-6min,沥油冷却,即得山药饼干。
上述制备方法,步骤1)选直径为1.5-2.5厘米,长16-19厘米的山药(优选的,选直径为2厘米,长18厘米的山药)。
上述制备方法,步骤2)切成硬币大小的方块,隔水蒸煮25-35分钟(优选的,切成硬币大小的方块,隔水蒸煮30分钟)。
上述制备方法,步骤3)将预处理好的原料放入打浆机内并且加入原料重量0.3-0.5倍的蜂蜜(优选的,将预处理好的原料放入打浆机内并且加入原料重量0.4倍的蜂蜜)。
上述制备方法,步骤4)细末过90-110目筛(优选的,细末过100目筛)。
上述制备方法,步骤5)待用手捏成团时用保鲜膜包裹发酵13-18分钟(优选的,待用手捏成团时用保鲜膜包裹发酵15分钟)。
上述制备方法,步骤6)油温控制在160-180℃,时间为3-5min(优选的,油温控制在170℃,时间为4min)。
最佳使用方法:为使该药达到最佳治疗效果,每次取本发明山药饼3-5块,可在每天的9点服用,也可以在饥饿的时候服用。
各原料药的药理功效分别为:
山药:健脾益胃,助消化:山药所含的能够分解淀粉的淀粉糖化酶,是萝卜中含量的3倍,胃胀时食用,有促进消化的作用,可以去除不适症状,有利于改善脾胃消化吸收功能,是一味平补脾胃的药食两用之佳品;滋肾益精:山药含有黏蛋白、淀粉酶、皂苷、游离氨基酸、多酚氧化酶等物质,且含量较为丰富,具有滋补作用,为病后康复食补之佳品,有强健机体、滋肾益精的作用;益肺止咳:山药含有皂苷、黏液质,有润滑、滋润的作用,故可益肺气、养肺阴,治疗肺虚痰嗽久咳之症;预防心血管病:山药几乎不含脂肪,而且所含的黏蛋白能预防心血管系统的脂肪沉积,防止动脉过早地发生硬化。山药含有皂苷能够降低胆固醇和甘油三酯,对高血压和高血脂等病症有改善作用;延年益寿:山药可增加人体T淋巴细胞,增强免疫功能,延缓细胞衰老;抗肝昏迷:山药所含的胆碱是与学习记忆有关的神经传递物质——乙酰胆碱的物质基础,研究发现山药具有镇静作用,可以抗肝昏迷;减肥健美:山药含有多种微量元素、丰富的维生素和矿物质,尤其钾的含量较高,所含热量又相对较低,经常食用,有减肥健美的作用。
石决明:又名鳆鱼甲、千里光、鲍鱼壳,为鲍科鲍属动物杂色鲍、皱纹盘鲍、羊鲍、澳洲鲍、耳鲍、白鲍等的贝壳。药性:味咸,性寒。成分:主要成分为碳酸钙,还有壳角质及胆素。根据现代药理研究发现,该药具有保肝、扩张气管、中和胃酸、明目去翳的功效,用于头痛眩晕,视物昏花,青盲雀目。
奶浆参:基原:为菊科还阳参属植物竹叶万丈深的根。药性:苦、甘,温。功用主治:补益肝肾,健脾利湿。主治头晕目眩,腰膝酸软,水肿,带下,缺乳,疳积。
青皮:为芸香科柑橘树植物橘及其栽培变种的幼果或未成熟果实的果皮。成分:青皮含升压有效成分:左旋辛弗林乙酸盐;还含天冬氨酸,谷氨酸,脯氨酸,甘氨酸,丙氨酸,胱氨酸,亮氨酸,异亮氨酸,苯丙氨酸等。药性:苦、辛,温。归肝、胆、胃经。功用主治:疏肝破气,消积化滞。主治胁肋、乳房、胃脘胀痛,乳核,乳痈,疝气,食积,症瘕积聚,久疟癖块。
七层楼:为萝藦科娃儿藤属植物七层楼的根。成分:含异娃儿藤碱及娃儿藤碱。药性:辛,温。小毒。功用主治:祛风化痰,活血止痛,解毒消肿。主治咳喘痰多,白喉,小儿惊风,风湿痹痛,跌打损伤,骨折,毒蛇咬伤,痈肿疮疖,赤眼,口腔炎,水肿,肝脾肿大。
昆布:为海带科(昆布科)海带属植物昆布及翅藻科昆布属植物黑昆布、裙带菜属植物裙带菜的叶状体。成分:1.昆布含多糖化合物,主要有三种:一种是褐藻酸盐,系褐藻酸及其钠、钾、铵、钙盐等;其次为岩藻依多糖;再者是海带淀粉等。2.黑昆布含褐藻酸及其钠盐,海带淀粉,甘露醇,维生素,卤化物,硫酸盐,磷酸盐,碘和其他微量元素灯。3.裙带菜全藻含多糖化合物,主要是褐藻酸,海带淀粉及脂多糖等。药性:咸,寒。归肝、胃、肾经。功用主治:软坚化痰,利水消肿。主治瘿瘤,瘰疬,颓疝,噎嗝,脚气水肿。
菟丝子:基原:为旋花科菟丝子属植物菟丝子的全草。成分:菟丝子含生物碱、蒽醌、香豆素、黄酮、甙类、甾醇、鞣酸、糖类等。黄酮类有:槲皮素、紫云英甙、金丝桃甙;甾醇类有:胆甾醇、菜油甾醇、β-谷甾醇、豆甾醇、β-香树脂醇。 亦含微量元素如锶、钼、钙、镁、铁、锰、锌、铜等以及多种氨基酸(种子中的游离氨基酸和水解后的总氨基酸为5.3%,其中必需氨基酸的含量占42.8%)。药性:微辛,甘,平,无毒。功用主治:补肾益精,养肝明目。适用于肝肾不足的腰膝筋骨酸痛,腿脚软弱无力、阳痿遗精、呓语、小便频数、尿有余沥、头晕眼花、视物不清、耳鸣耳聋以及妇女带下、习惯性流产等症。
菖蒲:别名九节菖蒲、水剑草、粉菖、山菖蒲、溪菖、石蜈蚣、野韭菜。性味功效:辛,平或微温。入心、肝、脾经。鲜品气味浓郁,辛散之力较之干品更胜,故为宣气通窍之佳品。本品既长于芳香化湿、醒脾健胃,用于治疗湿浊阴滞中焦,气机不畅、胸脘闷胀、不思饮食诸症;且又能芳华痰浊,开窍宁神,用于治疗湿浊蒙蔽清窍所引起的神智昏乱,舌苔白腻之症;并擅治痰热堕滞心包所致的神识不清,抽搐等症。
马铃薯:马铃薯块茎含有多种维生素和无机盐。食用马铃薯有益于健康与维生素的作用是分不开的。特别是维生素C可防止坏血病,刺激造血机能等,在日常吃的大米、白面中是没有的,而马铃薯可提供大量的维生素c。块茎中还含有维生素A(胡萝卜素)、维生素B1,(硫胺素)、维生素B2(核黄素)、维生素pp(烟酸)、维生素E(生育酚)、维生素B3(泛酸)、维生素B6(吡哆醇)、维生素M(叶酸)和生物素H等,对人体健康都是有益的。此外,块茎中的无机盐如钙、磷、铁、钾、钠、锌,锰等,也是对人的健康和幼儿发育成长不可缺少的元素。可以用来主治胃痛、痄肋、痈肿、湿疹、烫伤,是和胃健中药和解毒消肿药,性平味甘。中医认为马铃薯“性平味甘无毒,能健脾和胃,益气调中,缓急止痛,通利大便。对脾胃虚弱、消化不良、肠胃不和、脘腹作痛、大便不畅的患者效果显著”。现代研究证明,马铃薯对调解消化不良有特效,是胃病和心脏病患者的良药及优质保健品。马铃薯富有营养,是抗衰老的食物之一。
苹果:苹果是美容佳品,既能减肥,又可使皮肤润滑柔嫩。苹果是种低热量食物,每10青苹果0克只产生60千卡热量;苹果中营养成份可溶性大,易被人体吸收,故有“活水”之称,有利于溶解硫元素,使皮肤润滑柔嫩。苹果中还有铜、碘、锰、锌、钾等元素,人体如缺乏这些元素,皮肤就会发生干燥、易裂、奇痒。苹果中的维生素C是心血管的保护神、心脏病患者的健康元素。苹果的性味温和,含有丰富的碳水化合物、维生素和微量元素,有糖类、有机酸、果胶、蛋白质、钙、磷、钾、铁、维生素A、维生素B、维生素C和膳食纤维,另含有苹果酸,酒石酸,胡萝卜素,是所有蔬果中营养价值最接近完美的一个。
胡萝卜:胡萝卜是一种质脆味美、营养丰富的家常蔬菜。中医认为它可以补中气、健胃消食、壮元阳、安五脏,治疗消化不良、久痢、咳嗽、夜盲症等有较好疗效,故被誉为“东方小人参”。用油炒熟后吃,在人体内可转化为维生素A,提高机体免疫力,间接消灭癌细胞。美国科学家的最新研究又证实:每天吃两根胡萝卜,可使血中胆固醇降低10%~20%;每天吃三根胡萝卜,有助于预防心脏疾病和肿瘤。胡萝卜中的主要营养素是β-胡萝卜素,它存在于胡萝卜的细胞壁中,而细胞壁是由纤维素构成,人体无法直接消化,唯有通过切碎、煮熟及咀嚼等方式,使其细胞壁破碎,β-胡萝卜素才能释放出来,为人体真正消化吸收利用。完好保持β-胡萝卜素等营养成分,与我们的食用与烹调方法有着极大的关系。
南瓜:维生素是人和动物维持正常的生理功能而必须从食物中获得的一类微量有机物质,在人体的生长、代谢、发育过程中发挥着重要的作用。如果长期缺乏某种维生素,会引起生理机能障碍而发生某种疾病,南瓜中就富含有维生素B、维生素C。南瓜性温,味甘无毒,入脾、胃二经,有润肺益气,化痰排脓,驱虫解毒,疗肺痈便秘,滋润毛囊壁、美容抗痘等功效。主治久病气虚、脾胃虚弱、化痰排脓、气短倦怠、便溏、糖尿病、蛔虫等病症。
大豆:大豆脂肪也具有很高的营养价值,这种脂肪里含有很多不饱和脂肪酸,容易被人体消化吸收。而且大豆脂肪可以阻止胆固醇的吸收,所以大豆对于动脉硬化患者来说,是一种理想的营养品。豆渣中的膳食纤维对促进良好的消化和排泄固体废物有着举足轻重的作用。适量地补充纤维素,可使肠道中的食物增大变软,促进肠道蠕动,从而加快了排便速度,防止便秘和降低肠癌的风险。同时,膳食纤维具有明显的降低血浆胆固醇、调节胃肠功能及胰岛素水平等功能。大豆粕是大豆用低温(40-60℃)浸提法提取油脂后的残粕副产品,呈粗粉状。因没有受到温度,大豆的抗胰蛋白酶、脲酶、血球凝集素、皂素、甲状腺肿诱发因子不会被破坏。大豆饼粕是使用最广、用量最多的植物性蛋白质原料。
本发明治疗肝硬化的山药饼“注重整体”,既可治病,又可强身预防疾病,这是有别于药物治疗的一大特点,而且本治疗肝硬化的山药饼完全根据中医中药原理制备而成,更加安全可靠,无任何毒副作用。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。
实施例1一种治疗肝硬化的山药饼,取下述重量配比的主要原料制备而成(每份取10g):山药30份,石决明2份,奶浆参6份,青皮5份,七层楼2份,昆布3份,菟丝子3份,菖蒲4份,马铃薯20份,苹果10份,胡萝卜10份,南瓜15份,大豆20份。
上述治疗肝硬化的山药饼的制备方法,步骤如下:
1)选材:选直径为1厘米,长15厘米的山药,选用色泽鲜艳皮薄的马铃薯,苹果选择水分少的,胡萝卜要选择白色水分多的,选用金黄色的圆的南瓜;
2)预处理:将山药、马铃薯、苹果、胡萝卜和南瓜分别清洗干净,去皮,再用清水冲洗2遍,切成硬币大小的方块,隔水蒸煮20分钟;
3)打浆:将预处理好的原料放入打浆机内并且加入原料重量0.2倍的蜂蜜,然后进行打浆,得到混合浆液;
4)制备辅料:将石决明、奶浆参、青皮、七层楼、昆布、菟丝子和菖蒲用清水清洗3遍,置于铁丝网上,于阴凉通风处,沥干水分,紫外杀菌后加入到粉碎机,粉碎成细末,过80目筛;
5)制备佐料,将大豆碾磨成豆面,过120目筛,将过筛后的豆面置于容器内,放入豆面2-3倍的面粉,加水,用筷子搅拌,待用手捏成团时用保鲜膜包裹发酵10分钟待用;
6)制备成品:将步骤3)与步骤4)所得物混匀,然后倒入步骤5)发酵好的面团里,用力揉搓成团,放入挤压机制成直径3cm,厚0.3cm的饼,油炸,油温控制在140℃,时间为2min,沥油冷却,即得山药饼干。
典型病例一:林XX,女,68岁,山东省济南市济阳人,退休工人,突然呕血1小时入院,患者去年7月份在某医院诊断为“肝硬化失代偿期”,患者于1小时前进食晚餐后出现恶心,呕出鲜红色血液,量约300ml,无血凝块,伴头晕、心悸、口干,入院后又呕鲜血约500ml,头昏、乏力,次晨共解柏油样便2次,每次约150g,患者有乙肝病史多年,确诊“肝硬化”1年余,由于患者不想将余生在医院度过,但是医生建议使用本发明山药饼进行治疗。
服用实施例1所得山药饼,服用10天,不适症状减轻;继续服用10天,头晕、心悸、口干消失;患者一直服用实施例1所得山药饼,使用期间无副作用,虽没有彻底治愈肝硬化,但是减轻了患者的病痛。
实施例2一种治疗肝硬化的山药饼,取下述重量配比的主要原料制备而成(每份取10g):山药80份,石决明6份,奶浆参10份,青皮10份,七层楼6份,昆布7份,菟丝子8份,菖蒲8份,马铃薯30份,苹果20份,胡萝卜30份,南瓜25份,大豆30份。
上述治疗肝硬化的山药饼的制备方法,步骤如下:
1)选材:选直径为3厘米,长20厘米的山药,选用色泽鲜艳皮薄的马铃薯,苹果选择水分少的,胡萝卜要选择白色水分多的,选用金黄色的圆的南瓜;
2)预处理:将山药、马铃薯、苹果、胡萝卜和南瓜分别清洗干净,去皮,再用清水冲洗2遍,切成硬币大小的方块,隔水蒸煮40分钟;
3)打浆:将预处理好的原料放入打浆机内并且加入原料重量0.6倍的蜂蜜,然后进行打浆,得到混合浆液;
4)制备辅料:将石决明、奶浆参、青皮、七层楼、昆布、菟丝子和菖蒲用清水清洗3遍,置于铁丝网上,于阴凉通风处,沥干水分,紫外杀菌后加入到粉碎机,粉碎成细末,过120目筛;
5)制备佐料,将大豆碾磨成豆面,过160目筛,将过筛后的豆面置于容器内,放入豆面3倍的面粉,加水,用筷子搅拌,待用手捏成团时用保鲜膜包裹发酵20分钟待用;
6)制备成品:将步骤3)与步骤4)所得物混匀,然后倒入步骤5)发酵好的面团里,用力揉搓成团,放入挤压机制成直径7cm,厚0.7cm的饼,油炸,油温控制在200℃,时间为6min,沥油冷却,即得山药饼干。
实施例3一种治疗肝硬化的山药饼,取下述重量配比的主要原料制备而成(每份取10g):山药40份,石决明3份,奶浆参7份,青皮6份,七层楼3份,昆布4份,菟丝子4份,菖蒲5份,马铃薯23份,苹果13份,胡萝卜15份,南瓜18份,大豆23份。
上述治疗肝硬化的山药饼的制备方法,步骤如下:
1)选材:选直径为1.5厘米,长16厘米的山药,选用色泽鲜艳皮薄的马铃薯,苹果选择水分少的,胡萝卜要选择白色水分多的,选用金黄色的圆的南瓜;
2)预处理:将山药、马铃薯、苹果、胡萝卜和南瓜分别清洗干净,去皮,再用清水冲洗2遍,切成硬币大小的方块,隔水蒸煮25分钟;
3)打浆:将预处理好的原料放入打浆机内并且加入原料重量0.3倍的蜂蜜,然后进行打浆,得到混合浆液;
4)制备辅料:将石决明、奶浆参、青皮、七层楼、昆布、菟丝子和菖蒲用清水清洗3遍,置于铁丝网上,于阴凉通风处,沥干水分,紫外杀菌后加入到粉碎机,粉碎成细末,过80-120目筛;
5)制备佐料,将大豆碾磨成豆面,过130目筛,将过筛后的豆面置于容器内,放入豆面2.3倍的面粉,加水,用筷子搅拌,待用手捏成团时用保鲜膜包裹发酵13分钟待用;
6)制备成品:将步骤3)与步骤4)所得物混匀,然后倒入步骤5)发酵好的面团里,用力揉搓成团,放入挤压机制成直径4cm,厚0.4cm的饼,油炸,油温控制在160℃,时间为3min,沥油冷却,即得山药饼干。
实施例4一种治疗肝硬化的山药饼,取下述重量配比的主要原料制备而成(每份取10g):山药70份,石决明5份,奶浆参9份,青皮9份,七层楼5份,昆布6份,菟丝子7份,菖蒲7份,马铃薯28份,苹果18份,胡萝卜25份,南瓜23份,大豆28份。
上述治疗肝硬化的山药饼的制备方法,步骤如下:
1)选材:选直径为2.5厘米,长19厘米的山药,选用色泽鲜艳皮薄的马铃薯,苹果选择水分少的,胡萝卜要选择白色水分多的,选用金黄色的圆的南瓜;
2)预处理:将山药、马铃薯、苹果、胡萝卜和南瓜分别清洗干净,去皮,再用清水冲洗2遍,切成硬币大小的方块,隔水蒸煮35分钟;
3)打浆:将预处理好的原料放入打浆机内并且加入原料重量0.5倍的蜂蜜,然后进行打浆,得到混合浆液;
4)制备辅料:将石决明、奶浆参、青皮、七层楼、昆布、菟丝子和菖蒲用清水清洗3遍,置于铁丝网上,于阴凉通风处,沥干水分,紫外杀菌后加入到粉碎机,粉碎成细末,过110目筛;
5)制备佐料,将大豆碾磨成豆面,过150目筛,将过筛后的豆面置于容器内,放入豆面2-3倍的面粉,加水,用筷子搅拌,待用手捏成团时用保鲜膜包裹发酵18分钟待用;
6)制备成品:将步骤3)与步骤4)所得物混匀,然后倒入步骤5)发酵好的面团里,用力揉搓成团,放入挤压机制成直径6cm,厚0.6cm的饼,油炸,油温控制在180℃,时间为5min,沥油冷却,即得山药饼干。
典型病例二:邹XX,男,45岁,山东省济南市平阴人士,因右上腹痛1周,来社区医院就诊,患者描述自一周前开始出现腹部不适,腹胀,右上腹明显,并有加重的趋势,患者说:“我觉得自己的肚子好像比以前大了,可吃东西没什么胃口,全身无力”,他告诉护士以前没得过胃病,可现在什么也不想吃,但最近的体重没有明显变化,30岁时查出澳抗阳性,以后也没有什么症状,由于工作需要经常与客户吃饭,每周2次以上,每次饮酒(白酒)100g/d以上,大约有肝硬化10年了,医生建议服用本发明山药饼。
服用实施例4所得山药饼,使用当天20天,腹胀,右上腹疼痛症状减轻,使用30天,抵抗力增强,饭量也渐增,不适症状改善,患者一直服用实施例4所得山药饼。
实施例5一种治疗肝硬化的山药饼,取下述重量配比的主要原料制备而成(每份取10g):山药55份,石决明4份,奶浆参8份,青皮7.5份,七层楼4份,昆布5份,菟丝子5.5份,菖蒲6份,马铃薯25份,苹果15份,胡萝卜20份,南瓜20份,大豆25份。
上述治疗肝硬化的山药饼的制备方法,步骤如下:
1)选材:选直径为2厘米,长18厘米的山药,选用色泽鲜艳皮薄的马铃薯,苹果选择水分少的,胡萝卜要选择白色水分多的,选用金黄色的圆的南瓜;
2)预处理:将山药、马铃薯、苹果、胡萝卜和南瓜分别清洗干净,去皮,再用清水冲洗2遍,切成硬币大小的方块,隔水蒸煮30分钟;
3)打浆:将预处理好的原料放入打浆机内并且加入原料重量0.4倍的蜂蜜,然后进行打浆,得到混合浆液;
4)制备辅料:将石决明、奶浆参、青皮、七层楼、昆布、菟丝子和菖蒲用清水清洗3遍,置于铁丝网上,于阴凉通风处,沥干水分,紫外杀菌后加入到粉碎机,粉碎成细末,过100目筛;
5)制备佐料,将大豆碾磨成豆面,过140目筛,将过筛后的豆面置于容器内,放入豆面2-3倍的面粉,加水,用筷子搅拌,待用手捏成团时用保鲜膜包裹发酵15钟待用;
6)制备成品:将步骤3)与步骤4)所得物混匀,然后倒入步骤5)发酵好的面团里,用力揉搓成团,放入挤压机制成直径5cm,厚0.5cm的饼,油炸,油温控制在170℃,时间为4min,沥油冷却,即得山药饼干。
试验例1实施例5所得治疗肝硬化的山药饼的临床应用:我们随机抽取了400名患者做实验(400名患者有不同程度的治疗肝硬化),平均分成实验组和对照组,其中女200例,男200例,试验之前,对该人群进行连续观察,记录症状及变化,随机分为两组,实验组及对照组,实验组使用实施例5所得产品,对照组只用治疗肝硬化的药物。
,疗效情况判定标准:1、有效,使用本品后,不适症状减轻或部分消失;2、无效,使用本品后,不适症状无变化。我们对实验数据进行了精确的统计和数理分析。
具体实验结果如下表:
表1:两组临床疗效比较【例】表1
表1
结果分析:实验组与对照组均能在观察期内达到治疗肝硬化效果,但是实验组的显效率及总有效率明显高于对照组,而且对照组中还出现了不良反应的病例,所以本发明实施例5所得山药饼在治疗肝硬化的方面具有显著的疗效,而且由于本品全部选择纯天然中原料经过适当的炮制,使用方便,且无任何毒副作用,也不会对神经系统造成负担,不会导致依赖成瘾。
Claims (10)
1.治疗肝硬化的山药饼,其特征在于:取下述重量配比的主要原料制备而成:山药30-80份,石决明2-6份,奶浆参6-10份,青皮5-10份,七层楼2-6份,昆布3-7份,菟丝子3-8份,菖蒲4-8份,马铃薯20-30份,苹果10-20份,胡萝卜10-30份,南瓜15-25份,大豆20-30份。
2.根据权利要求4所述的治疗肝硬化的山药饼,其特征在于:取下述重量配比的主要原料制备而成:山药40-70份,石决明3-5份,奶浆参7-9份,青皮6-9份,七层楼3-5份,昆布4-6份,菟丝子4-7份,菖蒲5-7份,马铃薯23-28份,苹果13-18份,胡萝卜15-25份,南瓜18-23份,大豆23-28份。
3.根据权利要求4所述的治疗肝硬化的山药饼,其特征在于:取下述重量配比的主要原料制备而成:山药55份,石决明4份,奶浆参8份,青皮7.5份,七层楼4份,昆布5份,菟丝子5.5份,菖蒲6份,马铃薯25份,苹果15份,胡萝卜20份,南瓜20份,大豆25份。
4.根据权利要求1-3任一项所述的治疗肝硬化的山药饼的制备方法,其特征在于:步骤如下:
1)选材:选直径为1-3厘米,长15-20厘米的山药,选用色泽鲜艳皮薄的马铃薯,苹果选择水分少的,胡萝卜要选择白色水分多的,选用金黄色的圆的南瓜;
2)预处理:将山药、马铃薯、苹果、胡萝卜和南瓜分别清洗干净,去皮,再用清水冲洗2遍,切成硬币大小的方块,隔水蒸煮20-40分钟;
3)打浆:将预处理好的原料放入打浆机内并且加入原料重量0.2-0.6倍的蜂蜜,然后进行打浆,得到混合浆液;
4)制备辅料:将石决明、奶浆参、青皮、七层楼、昆布、菟丝子和菖蒲用清水清洗3遍,置于铁丝网上,于阴凉通风处,沥干水分,紫外杀菌后加入到粉碎机,粉碎成细末,过80-120目筛;
5)制备佐料,将大豆碾磨成豆面,过120-160目筛,将过筛后的豆面置于容器内,放入豆面2-3倍的面粉,加水,用筷子搅拌,待用手捏成团时用保鲜膜包裹发酵10-20分钟待用;
6)制备成品:将步骤3)与步骤4)所得物混匀,然后倒入步骤5)发酵好的面团里,用力揉搓成团,放入挤压机制成直径3-7cm,厚0.3-0.7cm的饼,油炸,油温控制在140-200℃,时间为2-6min,沥油冷却,即得山药饼干。
5.根据权利要求4所述的制备方法,其特征在于:步骤1)选直径为1.5-2.5厘米,长16-19厘米的山药(优选的,选直径为2厘米,长18厘米的山药)。
6.根据权利要求4所述的制备方法,其特征在于:步骤2)切成硬币大小的方块,隔水蒸煮25-35分钟(优选的,切成硬币大小的方块,隔水蒸煮30分钟)。
7.根据权利要求4所述的制备方法,其特征在于:步骤3)将预处理好的原料放入打浆机内并且加入原料重量0.3-0.5倍的蜂蜜(优选的,将预处理好的原料放入打浆机内并且加入原料重量0.4倍的蜂蜜)。
8.根据权利要求4所述的制备方法,其特征在于:步骤4)细末过90-110目筛(优选的,细末过100目筛)。
9.根据权利要求4所述的制备方法,其特征在于:步骤5)待用手捏成团时用保鲜膜包裹发酵13-18分钟(优选的,待用手捏成团时用保鲜膜包裹发酵15分钟)。
10.根据权利要求4所述的制备方法,其特征在于:步骤6)油温控制在160-180℃,时间为3-5min(优选的,油温控制在170℃,时间为4min)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510554570.XA CN105076994A (zh) | 2015-09-03 | 2015-09-03 | 治疗肝硬化的山药饼及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510554570.XA CN105076994A (zh) | 2015-09-03 | 2015-09-03 | 治疗肝硬化的山药饼及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105076994A true CN105076994A (zh) | 2015-11-25 |
Family
ID=54559048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510554570.XA Pending CN105076994A (zh) | 2015-09-03 | 2015-09-03 | 治疗肝硬化的山药饼及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105076994A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106982906A (zh) * | 2017-05-11 | 2017-07-28 | 许昌学院 | 一种葛根风味饼干及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102232403A (zh) * | 2010-05-04 | 2011-11-09 | 曲家梅 | 一种山药食品及其加工方法 |
CN102940217A (zh) * | 2012-12-04 | 2013-02-27 | 李韵婷 | 一种山药饼及其制作方法 |
CN104054876A (zh) * | 2014-05-26 | 2014-09-24 | 安徽省怀远县三源食品有限责任公司 | 一种拔丝山药南瓜饼及其制备方法 |
CN104095004A (zh) * | 2014-06-16 | 2014-10-15 | 安徽乐健绿色食品有限公司 | 一种葡萄干山药饼干 |
-
2015
- 2015-09-03 CN CN201510554570.XA patent/CN105076994A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102232403A (zh) * | 2010-05-04 | 2011-11-09 | 曲家梅 | 一种山药食品及其加工方法 |
CN102940217A (zh) * | 2012-12-04 | 2013-02-27 | 李韵婷 | 一种山药饼及其制作方法 |
CN104054876A (zh) * | 2014-05-26 | 2014-09-24 | 安徽省怀远县三源食品有限责任公司 | 一种拔丝山药南瓜饼及其制备方法 |
CN104095004A (zh) * | 2014-06-16 | 2014-10-15 | 安徽乐健绿色食品有限公司 | 一种葡萄干山药饼干 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106982906A (zh) * | 2017-05-11 | 2017-07-28 | 许昌学院 | 一种葛根风味饼干及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103340334B (zh) | 一种淡水鱼饲料及其制备方法 | |
CN101816440B (zh) | 保健滋补油焖虾 | |
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN102511869B (zh) | 红枣生姜浓浆 | |
CN104643250A (zh) | 一种可双向调节体重改善亚健康的固体饮料 | |
CN105875781A (zh) | 一种中药保健饼干及其制备方法 | |
CN102871100B (zh) | 一种姜竹盐及其制备方法 | |
CN105394637A (zh) | 玛卡虫草黑枸杞茯苓保健山楂糕及其制备工艺 | |
KR100336649B1 (ko) | 장 청소 및 변비 해소 기능의 야채 효소 음료 조성물 | |
KR101632794B1 (ko) | 흰점박이 꽃무지를 주재료로 하는 환의 제조방법 | |
KR20090127970A (ko) | 생식환의 조성물 및 이의 제조 방법 | |
CN105767110A (zh) | 一种保健蛋糕及其制备方法 | |
CN104873826A (zh) | 一种可清肺祛湿的茶饮及其制备方法 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN104351380A (zh) | 减肥茶及制作方法 | |
CN103908592A (zh) | 一种解毒的中药及其制备方法 | |
CN104397717B (zh) | 玉米抗便秘减肥健康食品及其生产方法 | |
CN105169093A (zh) | 一种调理血脂血压的组合物及其制备方法 | |
CN105076994A (zh) | 治疗肝硬化的山药饼及其制备方法 | |
CN103859403A (zh) | 植物甾醇油氽魔芋的食品及其生产方法 | |
CN107712890A (zh) | 一种宁心安神膏滋及其制备方法 | |
KR20180056199A (ko) | 모링가추출물을 함유한 다이어트용 껌의 제조방법 | |
CN106035488A (zh) | 一种富有机铬营养保健饼干及其制备方法 | |
CN105105127A (zh) | 一种红果舒心粉多功能保健食品 | |
CN109588551A (zh) | 一种治疗代谢病的饲料添加剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151125 |
|
RJ01 | Rejection of invention patent application after publication |